Free Trial

UiPath, Inc. (NYSE:PATH) CEO Daniel Dines Sells 45,000 Shares

UiPath logo with Computer and Technology background

UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of the stock in a transaction dated Wednesday, July 16th. The stock was sold at an average price of $12.43, for a total value of $559,350.00. Following the transaction, the chief executive officer directly owned 5,058,376 shares in the company, valued at approximately $62,875,613.68. The trade was a 0.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Daniel Dines also recently made the following trade(s):

  • On Wednesday, July 16th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.43, for a total value of $559,350.00.
  • On Monday, July 14th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.44, for a total value of $559,800.00.
  • On Friday, July 11th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.71, for a total value of $571,950.00.
  • On Wednesday, July 9th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $13.17, for a total value of $592,650.00.
  • On Monday, July 7th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $13.11, for a total value of $589,950.00.
  • On Wednesday, July 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.54, for a total value of $564,300.00.
  • On Monday, June 30th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total value of $575,100.00.
  • On Friday, June 27th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total value of $575,100.00.
  • On Wednesday, June 25th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.55, for a total value of $564,750.00.
  • On Monday, June 23rd, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.10, for a total value of $544,500.00.

UiPath Stock Up 0.6%

Shares of NYSE PATH traded up $0.08 on Friday, hitting $12.41. The company had a trading volume of 481,392 shares, compared to its average volume of 10,285,122. The firm has a market capitalization of $6.64 billion, a P/E ratio of -103.37, a PEG ratio of 16.24 and a beta of 1.04. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93. The business has a 50 day moving average of $12.75 and a two-hundred day moving average of $12.45.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The firm had revenue of $356.62 million during the quarter, compared to the consensus estimate of $332.17 million. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. UiPath's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.13 earnings per share. On average, sell-side analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on PATH. Barclays reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. BMO Capital Markets lifted their price objective on UiPath from $11.50 to $15.50 and gave the company a "market perform" rating in a research report on Friday, May 30th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. Scotiabank lifted their price objective on UiPath from $12.00 to $13.00 and gave the company a "sector perform" rating in a research report on Friday, May 30th. Finally, Morgan Stanley lifted their price objective on UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a research report on Monday, June 2nd. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $13.83.

View Our Latest Report on PATH

Institutional Trading of UiPath

Institutional investors and hedge funds have recently made changes to their positions in the stock. Versant Capital Management Inc increased its position in UiPath by 198.6% in the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after acquiring an additional 1,970 shares during the period. AdvisorNet Financial Inc increased its position in UiPath by 320.4% in the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after acquiring an additional 1,887 shares during the period. CX Institutional acquired a new stake in UiPath in the 1st quarter valued at approximately $36,000. EverSource Wealth Advisors LLC increased its position in UiPath by 141.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock valued at $38,000 after acquiring an additional 1,742 shares during the period. Finally, GAMMA Investing LLC boosted its stake in UiPath by 48.0% during the 2nd quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock valued at $38,000 after purchasing an additional 969 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Strategy Beat the S&P—And Most Investors Ignore It
Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines